PIK3CA mutation / PTEN expression status predicts response of colon cancer cells to the EGFR inhibitor cetuximab

Por Jhawer, Minaxi, Goel, Sanjay, Wilson, Andrew J., Montagna, Cristina, Ling, Yi-He, Byun, Do-Sun, Nasser, Shannon, Arango, Diego, Shin, Joongho, Klampfer, Lidija, Augenlicht, Leonard H., Soler, Roman Perez, Mariadason, John M.
Publicado em 2008